相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families
Xin Yang et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D
Xin Yang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2020)
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification
Michael T. Parsons et al.
HUMAN MUTATION (2019)
Performance of in silico prediction tools for the classification of rare BRCA1/2 missense variants in clinical diagnostics
Corinna Ernst et al.
BMC MEDICAL GENOMICS (2018)
BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2
Melissa S. Cline et al.
PLOS GENETICS (2018)
Assessment of in silico protein sequence analysis in the clinical classification of variants in cancer risk genes
Iain D. Kerr et al.
JOURNAL OF COMMUNITY GENETICS (2017)
BRCA1 and BRCA2 genetic testing-pitfalls and recommendations for managing variants of uncertain clinical significance
D. M. Eccles et al.
ANNALS OF ONCOLOGY (2015)
Splicing analysis of 14 BRCA1 missense variants classifies nine variants as pathogenic
Lise B. Ahlborn et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Hereditary Diffuse Gastric Cancer Syndrome CDH1 Mutations and Beyond
Samantha Hansford et al.
JAMA ONCOLOGY (2015)
Variability in pathogenicity prediction programs: impact on clinical diagnostics
Lauren C. Walters-Sen et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2015)
ClinVar: public archive of relationships among sequence variation and human phenotype
Melissa J. Landrum et al.
NUCLEIC ACIDS RESEARCH (2014)
Lifetime Cancer Risks in Individuals with Germline PTEN Mutations
Min-Han Tan et al.
CLINICAL CANCER RESEARCH (2012)
Classification of Missense Substitutions in the BRCA Genes: A Database Dedicated to Ex-UVs
Maxime P. Vallee et al.
HUMAN MUTATION (2012)
ENIGMA-Evidence-Based Network for the Interpretation of Germline Mutant Alleles: An International Initiative to Evaluate Risk and Clinical Significance Associated with Sequence Variation in BRCA1 and BRCA2 Genes
Amanda B. Spurdle et al.
HUMAN MUTATION (2012)
Improving the Assessment of the Outcome of Nonsynonymous SNVs with a Consensus Deleteriousness Score, Condel
Abel Gonzalez-Perez et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2011)
Risk of Breast Cancer in Women With a CHEK2 Mutation With and Without a Family History of Breast Cancer
Cezary Cybulski et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Comprehensive Analysis of Missense Variations in the BRCT Domain of BRCA1 by Structural and Functional Assays
Megan S. Lee et al.
CANCER RESEARCH (2010)
A method and server for predicting damaging missense mutations
Ivan A. Adzhubei et al.
NATURE METHODS (2010)
Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes
Suzanne C. O'Neill et al.
PSYCHO-ONCOLOGY (2009)
Sequence Variant Classification and Reporting: Recommendations for Improving the Interpretation of Cancer Susceptibility Genetic Test Results
Sharon E. Plon et al.
HUMAN MUTATION (2008)
Frequency and spectrum of cancers in the Peutz-Jeghers syndrome
Nicholas Hearle et al.
CLINICAL CANCER RESEARCH (2006)
Cancer risks and mortality in heterozygous ATM mutation carriers
D Thompson et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Predicting deleterious amino acid substitutions
PC Ng et al.
GENOME RESEARCH (2001)
BRCA1 and BRCA2 and the genetics of breast and ovarian cancer
PL Welcsh et al.
HUMAN MOLECULAR GENETICS (2001)
分享论文
